Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Perspectum
- Study ID
- NCT04054310
- Status
- Recruiting
Conditions
- NASH - Nonalcoholic Steatohepatitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Liver Multi Scan — DIAGNOSTIC_TESTMRI to create cT1, T2\* and PDFF images of patients liver.
Study Details
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Key Dates
- Start date
- Aug 5, 2020
- Status verified
- May 2026
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2026
Study Design
- Enrollment
- 225 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Study-gateSingle arm of biopsy naïve participants suspected of having NAFLD or NASH, who have been referred for a liver biopsy as part of routine clinical care
Primary Outcome Measure
Diagnostic performance of cT1 [ Time Frame: 12 months ]
Central Contacts
- Cayden Beyer01865655343
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arizona Liver Health | Chandler | Arizona | 85224 | David Rios, MD Naim Alkhouri, MD (PRINCIPAL_INVESTIGATOR) |
| RUSH University Medical Center | Chicago | Illinois | 60612 | Lelani Fetrow, BSN Nancy Reau, MD (PRINCIPAL_INVESTIGATOR) |
| Indiana University Health | Indianapolis | Indiana | 46202 | Sreemala Murthy, BSc Raj Vuppalanchi, MD (PRINCIPAL_INVESTIGATOR) |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Elianna Sanchez Douglas Dieterich (PRINCIPAL_INVESTIGATOR) |
| Liver Center of Texas | Dallas | Texas | 75234 | - |
| University of Virginia | Charlottesville | Virginia | 22908 | Cheree Denbee Zachary Henry (PRINCIPAL_INVESTIGATOR) |
| Virginia Common wealth University | Richmond | Virginia | 23284 | Arun Sanyal (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chandler, AZ
Related Studies
- Investigating the Link Between Type 2 Immunity and NAFLD in Human ObesityRecruiting · Mayo Clinic · Scottsdale, Arizona
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHPHASE3 · Recruiting · Akero Therapeutics, Inc · Birmingham, Alabama
- Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic SteatohepatitisRecruiting · University of Minnesota · San Francisco, California
- Estrogen Administration for the Treatment of NASH in Postmenopausal WomenPHASE3 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts